LL37 LL37 fusion protein with increased immune response induction ability and vaccine composition for preventing or treating Middle East respiratory syndrome comprising the same as effective component

摘要

The present invention relates to an LL37 fusion protein having an increased ability to induce an immune response consisting of the amino acid sequence of SEQ ID NO: 2 and a vaccine composition for preventing or treating Middle East Respiratory Syndrome containing the same as an active ingredient.